Traumatic Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs

Status Completed

Clinical Trial Summary

Oral antithrombotic medications (OAM) are used for the prevention and treatment of thrombotic disorders. Among hemorrhagic complications of OAMs, intracranial hemorrhage (ICH) may have particularly devastating consequences with high morbidity, disability and mortality rates. The efficacy and safety profiles of OAMs are generally assessed in randomized controlled trials (RCT), but included patients are often highly selected and may not be representative of users in everyday clinical practice in terms of follow-up routines, age, gender, drug compliance, and polypharmacy. Moreover, it is often unclear whether or not traumatic ICHs are registered and reported in RCTs. Drifts in indications and treatment criteria may also be seen in everyday practice and drug discontinuation due to precautionary concerns including compliance, fall risk and comorbidity may be forgotten. Collectively, these factors may lead to other and potentially higher traumatic ICH rates in general clinical use than reported in RCTs.

The incidence rates of traumatic ICH in patients on OAMs in the general population remain unknown. In this nationwide registry based pharmacoepidemiological study we will investigate the incidence and case fatality of traumatic ICH in users of OAMs in Norway from 2008 through 2014.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02996851
Study type	Observational
Source	St. Olavs Hospital
Contact
Status	Completed
Phase	N/A
Start date	January 2007
Completion date	December 31, 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04304651` - Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism	N/A
Completed	`NCT00216866` - The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis	Phase 2
Recruiting	`NCT05907564` - Aventus Thrombectomy System Pulmonary Embolism Clinical Study	N/A
Completed	`NCT05128591` - A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091	Phase 1
Completed	`NCT00670540` - Epidemiology of Thromboembolism Disease: A Cohort Study	N/A
Recruiting	`NCT04263038` - Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism	Phase 4
Recruiting	`NCT04388657` - COVID-19, bLOod Coagulation and Thrombosis
Completed	`NCT04439383` - Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
Completed	`NCT01897103` - Platelet Activity in Vascular Surgery for Thrombosis and Bleeding	N/A
Recruiting	`NCT04657120` - Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy	N/A
Completed	`NCT02720328` - Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants	Phase 4
Completed	`NCT01203098` - A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty	Phase 2
Completed	`NCT00830570` - The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings	N/A
Recruiting	`NCT05568966` - Collection of Blood Samples for New Diagnostic Devices 2	N/A
Not yet recruiting	`NCT06209892` - Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis	N/A
Completed	`NCT01086215` - Registry of AngioJet Use in the Peripheral Vascular System	N/A
Completed	`NCT00119457` - Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)	Phase 2
Recruiting	`NCT05853796` - Observational Dutch Young Symptomatic StrokE studY - nEXT
Terminated	`NCT02610608` - Medical Assistance for the Procreation and Risk of Thrombosis.
Completed	`NCT04368377` - Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19	Phase 2